Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: Synthesis and evaluation of different chitosan-EDTA conjugates

Journal of Controlled Release

Volumn 50, Issue 1-3, 1998, Pages 215-223

  Bernkop Schnürch, Andreas ^a   Krajicek, Martina E ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chitosan EDTA conjugate; Inhibition of luminal proteases; Mucoadhesion; Peroral administration of (poly)peptides

Indexed keywords

CALCIUM; CARBOXYPEPTIDASE A; CHITOSAN; COBALT; EDETIC ACID; ELASTASE; MICROSOMAL AMINOPEPTIDASE; POLYMER; SERINE PROTEINASE; TRYPSIN; ZINC;

ADHESION; ARTICLE; BINDING AFFINITY; CONJUGATION; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; MUCOSA; PRIORITY JOURNAL; PROTEIN DEGRADATION; STRUCTURE ANALYSIS; TENSILE STRENGTH; VISCOSITY;

ABSORPTION; ADHESIVENESS; ADMINISTRATION, ORAL; CALCIUM; CHITIN; CHITOSAN; COBALT; DRUG DELIVERY SYSTEMS; EDETIC ACID; MUCINS; PROTEASE INHIBITORS; ZINC;

EID: 0032472305     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00136-3     Document Type: Article

References (25)

1. Woodley J.F. Enzymatic barriers for GI peptide and protein delivery. Crit. Rev. Ther. Drug. 11:1994;61-95.
2. Bernkop-Schnürch A., Fragner R. Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration. Pharm. Sci. 2:1996;361-363.
3. Pusztai A. Transport of proteins through the membranes of the adult gastro-intestinal tract - a potential for drug delivery? Adv. Drug Deliv. Rev. 3:1989;215-228.
4. Kolac C., Streichhan P., Lehr C.-M. Oral bioavailability of proteolytic enzymes. Eur. J. Pharm. Biopharm. 42:1996;222-232.
5. Bernkop-Schnürch A. Strategien zur peroralen Applikation von Peptid- und Proteinwirkstoffen. Sci. Pharm. 47:1997;113-121.
6. Junginger H.E. Bioadhesive polymer systems for peptide delivery. Acta Pharm. Technol. 36:1990;110-126.
7. Lehr C.-M. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit. Rev. Ther. Drug. 11:1994;119-160.
8. Lueßen H.L., Verhoef J.C., Borchard G., Lehr C.-M., de Boer A.G., Junginger H.E. Mucoadhesive polymers in the peroral peptide drug delivery: II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm. Res. 12:1995;1293-1298.
9. Lueßen H.L., de Leeuw B.J., Pérard D., Lehr C.-M., de Boer A.G., Verhoef J.C., Junginger H.E. Mucoadhesive polymers in peroral peptide drug delivery. I. Influence of mucoadhesive excipients on the proteolytic activity of intestinal enzymes. Eur. J. Pharm. Sci. 4:1996;117-128.
10. Bernkop-Schnürch A., Marschütz M.K. Development and in vitro evaluation of systems to protect peptide drugs from aminopeptidase N. Pharm. Res. 14:1997;181-185.
11. Lueßen H.L., Bohner V., Pérard D., Langguth P., Verhoef J.C., de Boer A.G., Merkle H.P., Junginger H.E. Mucoadhesive polymers in peroral peptide drug delivery. V. Effect of poly(acrylates) on the enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles. Int. J. Pharm. 141:1996;39-52.
12. Pesavento M., Biesuz R., Gallorini M., Profumo A. Sorption mechanism of trace amounts of divalent metal ions on a chelating resin containing iminodiacetate groups. Anal. Chem. 65:1993;2522-2527.
13. Bernkop-Schnürch A., Paikl Ch., Valenta C. Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N. Pharm. Res. 14:1997;917-922.
14. Bernkop-Schnürch A., Apprich I. Synthesis and evaluation of a modified mucoadhesive polymer protecting from α-chymotrypsinic degradation. Int. J. Pharm. 146:1997;247-254.
15. A. Bernkop-Schnürch, N.C. Göckel, Development and analysis of a polymer protecting from luminal enzymatic degradation caused by α-chymotrypsin, Drug Dev. Ind. Pharm. (1996) in press.
16. Bernkop-Schnürch A., Schwarz G., Kratzel M. Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides. J. Control. Release. 47:1997;113-121.
17. Ch'ng H.S., Park H., Kelly P., Robinson J.R. Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J. Pharm. Sci. 74:1985;399-405.
18. Lehr C.-M., Bouwstra J.A., Schacht E.H., Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78:1992;43-48.
19. Mortazavi S.A. An in-vitro assessment of mucus adhesive interactions. Int. J. Pharm. 124:1995;173-182.
20. Sanderink G.-J., Artur Y., Siest G. Human aminopeptidases: a review of the literature. J. Clin. Chem. Clin. Biochem. 26:1988;795-807.
21. F. Seel, Grundlagen der analytischen Chemie, Verlag Chemie, Weinheim, Germany, 1976.
22. Bernkop-Schnürch A., Dundalek K. Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation. Int. J. Pharm. 138:1996;75-83.
23. 2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm. Res. 5:1988;305-308.
24. Aungst B.J., Saitoh H., Burcham D.L., Huang S.-M., Mousa S.A., Hussain M.A. Enhancement of the intestinal absorption of peptides and non-peptides. J. Control. Release. 41:1996;19-31.
25. Lueßen H.L., Rentel C.-O., Kotzé A.F., Lehr C.-M., de Boer A.G., Verhoef J.C., Junginger H.E. Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. J. Control. Release. 45:1997;15-23.